Fibrosis can result from repeated episodes of rejection, ischemic injury [30], or other forms of graft damage, a possible physiopathological mechanism being the direct activation of fibroblasts by a subset of T lymphocytes through the production of profibrotic cytokines, interleukin 4, and interleukin 13 [30]. This evidence concerns the gene IL13 and fibrosis.